Mesh Bio aims to transform health screening and chronic disease management by building a predictive analytics platform. The startup works with healthcare providers and stakeholders and translates complex clinical data and numbers into actionable insights for clinical practice – to help patients better manage their
The Medical Algorithms Company supports providers and payers with analytics and documentation for evidence-based medical practice, covering a broad range of diagnostics, treatment and readmission predictors. The online platform supplies over 27,000 tested medical calculators and analytic risk scores to improve the decision-making process.
Us2.ai is fighting against cardiovascular diseases using machine learning to automate the reading of echocardiograms. The software provides a research database as well as ready-to-use segmentation models and validation cohorts for the early detection of cardiovascular risks. Indication area: Cardiometabolic Diseases